LAS VEGAS, Jan. 2, 2025 /PRNewswire/ -- THIRDREALITY, a leader in the smart home technology industry, is excited to present its latest breakthroughs at CES 2025, which promise to enhance the daily living experience through superior integration and functionality. Visit us at the Venetian Expo, Booth 52565 from January 7-10.
This year, THIRDREALITY is thrilled to unveil several key products, each designed to address specific aspects of home automation and user convenience:
- Smart Hub Gen3: Supports both Zigbee and Matter protocols. With local storage, cloud services, and local routine support, you can enjoy exceptional smart home control. Whether it's home automation or remote management, experience reliable and efficient smart living.
- Motion Sensor R1: Powered by a 5.8G mmWave radar sensor for customizable detection with adjustable sensitivity. Battery-powered for easy installation, making smart home integration effortless and seamless.
- Smart Switch MT1: The first Thread product of THIRDREALITY. This product embodies the brand's commitment to innovation, leveraging advanced Thread technology for exceptional responsiveness and seamless smart home integration, paving the way for the future of smart living.
- Smart Plug with Wi-Fi Sense: Transform your Wi-Fi into a powerful motion-sensing network with WiFi Motion. This camera-free, AI-driven solution provides motion alerts and analysis while safeguarding your privacy.
- Smart Blind Gen2: Designed for large windows (34 to 80 inches) and equipped with dual motors for smooth operation. With up to 1.5 years of battery life, it supports customization for various window needs.
- Water Leak Sensor KM1: Protect your home with our comprehensive water leak detection kit—featuring an 80-meter range, customizable alarm alerts, and seamless Matter compatibility. Stay connected and secure with reliable, scalable leak monitoring.
THIRDREALITY will also introduce the ListenCare Senior Speaker, a sound solution designed specifically for seniors with hearing impairments. This speaker enhances the daily lives of the elderly by offering clear, customizable audio. Featuring ultra-low latency technology, it ensures perfect synchronization between audio and visual media, while flexible volume control and personalized sound frequency settings allow users to adjust audio to their specific hearing needs. Whether for watching TV or enjoying music, the ListenCare Senior Speaker ensures every note and word is crystal clear, making it a perfect addition to any senior's home environment. This innovative product highlights THIRDREALITY's commitment to enhancing accessibility and quality of life for the elderly through smart technology.
We invite all CES attendees to our booth to experience these transformative technologies in action. For more information about THIRDREALITY and our range of products, please visit our official website at www.3reality.com.
About Third Reality:
Third Reality is a smart home technology company, dedicated to developing high-quality, user-friendly, and secure smart home products. Through continuous innovation and a deep understanding of market needs, the company strives to provide an improved smart home experience for users worldwide.
For more information, please visit www.3reality.com or follow our social media platforms.
Related Links:
Facebook: https://www.facebook.com/ThirdReality.offical
Twitter: https://twitter.com/thirdrealityinc
YouTube: https://www.youtube.com/channel/UCG_rpEZrPoJNErGtvh5juHg
TikTok: https://www.tiktok.com/@thirdrealityofficial
Instagram: https://www.instagram.com/thirdreality_inc
Media Contact:
Tina Zhu
Marketing Manager
Third Reality, Inc.
info@3reality.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
THIRDREALITY Showcases Latest Innovations in Smart Home Technology at CES 2025
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
